Coldstream Capital Management Inc Alkermes Plc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 4,105 shares of ALKS stock, worth $128,897. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,105Holding current value
$128,897% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
394Shares Held
174MCall Options Held
280KPut Options Held
175K-
Black Rock Inc. New York, NY29.1MShares$914 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$572 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$370 Million0.05% of portfolio
-
State Street Corp Boston, MA8.81MShares$277 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$237 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.16B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...